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Letters to the editors 
Dear Dr. Malone: 
It is encouraging to see an effort being made by the Pacific 
Information Service on Street-Drugs to provide the p~th 
valid information regarding drugs of misuse. The Cincinnati Drug 
and Poison Information Center concerns itself with similar attempts 
at dissemination of valid information. 
I would like to comment on a statement made in Bulletin No. 6, p. 32 
11A dose of Reds properly injected into a vein travels back to the 
heart where it is pumped into all arteries of the body. In this way 
the barbiturate salt is diluted and each tissue receives only a 
small portion of the total dose. In this way the problem of pain, 
tissue damage and possible gangrene are avoided. 11 The difficulties 
I have with this statement are: 1. The term "reds" is non specific 
and may encompass any commercial or street dosage form of seco-
barbital; 2. None of the commercial or street dosage forms are 
sterile and thus may result in various infections when injected 
i. v.; 3. Many commercial and street dosage forms of secobarbital 
contain finely divided particles of material which are not soluble 
in blood and thus do not dissolve at all, eg. talc, fil);i:s, binders, 
etc. These materials have been shown to cause serious pulmonary, 
renal and neurologic deficit, by virtue of the fact that they lodge 
in arterioles and capillary beds producing obstruction to blood 
flow which results in tissue anoxia, degeneration, necrosis and 
fibrosis.(1,2,3,4,5,6,7,8,9,10,11) For these reasons, I feel that 
the statement 11 In this way the problems of pain, tissue damage and 
possible gangrene are avoided. 11 is misleading to the lay public in 
that they may assume that there is no other danger than CNS dep-
ression of the respiratory center from the i. v. injection of the 
contents of a secobarbital capsule. 
This communication is meant as constructive criticism and it is 
my hope that it will be received in that light. 
Sincerely, 
E. Don Nelson, Pharm. D. 
Associate Director 
Drug and Poison Information Center 
234 Goodman Street 
Cincinnati, Ohio 45229 
References: 
~ :g~~~~~;~!~A:o~· A~~~·~::0ti~iU2, 1968. 
J.Karliner,J.S. ~· ~· ~., .!.!j:350, 1969. 
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Street Spee d . 
The analysis, i n our l aboratory , of 19 samples of street-drugs 
alleged to be amphetamines resulted in a positive amphetamine 
r esponse for 17 of t he samples and most of these samples ( 16) 
were "White Crosses " . However , whil e amphetamines are usually 
amphetamines in the s treet ma rket , the amount of dr ug may vary 
from a low of 2. 5 mg . to a high of 10 mg. per tablet in the 
"Whit e Crosses 11 ( 1). Three tablets of a low potency tablet may 
be just the right amount to produc e the euphori a and feeli ngs 
of ~onfidence that the user desi r es . However , if the user gets 
a !ugh pot ency tablet and again cons um es three tablets, a toxic 
reaction may be precipitated -- a reaction difficult to manage 
safely lvithout medical help . 
Treatment of amphet amine overdosage should include acidification 
of urine , which r equires hospitalization . To re duce the acute 
anxiety , the purposel ess hyperactivity and to prevent possibl e 
convuls~ons , remov e all noxious stimuli s uch as bright lights, 
loud no1se and music f rom the subj ect's environment . Do not 
i nduce vomiting and do not give barbiturates {2 ). 
Due to increasing concern ove r the adve r se effects induced by 
the misuse of amphetami nes , these drugs recently have been 
subj ected to intense i nvestigation. In 1970, the Food and Drug 
Admini stration (FDA) r estricted t he l ega l use of the amphet-
amines to t hree types of conditions : in obesity, for overactive 
(hyperkinetic ) childt•en, and fo r i ndividuals who compulsivel y 
fa ll asl ee p duri ng the daytime -- a condition knmm as narc-
olepsy ( 3 ) . Toda y, more effective drugs and drugs with l ess 
dependence potential ar e avai labl e for each of t hese uses . The 
amphetamines now have no pla ce in t he rapeutics -- however 
their product ion continues. NearlY all of this chemical is' either 
l egally misused or channel ed i nto t he street market. 
The following are common types of misuse : 
1 · The amphetamine-barbiturate cycle prevel ant in America . 
This type of mis use is found pr i marily among bus iness men in 
their 30 1 s and women between 20 and 30 years of age ( 4) . The 
amphetamine provides a feel-fine / fast-start f or a long work 
~ay, at the end of which, a pseudo- s l ee p is induced by a barb-
lturate. The hang-over from this "sleep" is t e rminat ed the foll-
OI~ing morning by taking another amphetamine ( 5) . Prolonged con-
tlnuatlon of this cycle l ea ds to combined amphetamine and barb-
iturate addiction, psychos i s , and physical dete riorat ion. 
2 ·Truck drivers , college student s , medical personnel, and thos e 
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with no cturna l occup ations use amphetamines t o combat fat i gue 
and bore dom and in cr anuning f or exams ( 4) . College stude nts 
begin t o t ake amphetamine and methamphetamine s upposing t hat .i t 
will make them brighter and mo re i nt elligent: This is a per f ect 
example of wish f ul ( and dangerous ) thinki ng . No drug ca n pr ovi de 
t est answers to a brain l a cki ng the st ore d f actual i nformation. 
Even wh en s tudents have s tudie d properl y a nd t hei r memo Py ba nk s 
a r e f ull of i nformation, the amphetami nes wil l not i mpro ve t heir 
performance i f t he test f ormat Pe quires an y process of l ogic . 
Regurgi t ation o f facts can be faci litat e d by t he amphetamines 
but corre l ation of fac t s , i nductive Peasoni ng , a nd mathematica l 
accu racy ap e all depressed . The mind does not th i nk l ogically 
i n any emotional stat e , 1vhethe r natuPal ly- induce d or drug-
induce d ( 6 ) . 
3 . The "S peed Freak" i s i n a c l ass by hi msel f . Spee d ( methamph-
et amine hydr ochlori de , a n amphetami ne anal ogue ) may be take n 
orally in tablet f or m or i nj ecte d int r avenous l y . No matteP 
what the rout e , a euphor ic dose wi ll al so pr oguce ne rv ous ness , 
hyper activity , loss of a ppet i t e , l oss of s l ee p, and atropine-
l ike si de effects ( i.e . dry mout h, cons t i pation, r a pi d hea r t 
rate etc . ) . I n a "r un" or "s peed binge" (hours or days of con-
tinually i nj ecting methamphetami ne every 2 or 3 hours ), tol erance 
(mor e and more drug to get the desi r e d effect ) will deve l op 
qui t e ra pidly s o that mass ive doses of 500 t o 1000 mg. may 
e ventually be i njected . The general effects of an intrave nous 
inj ect i on have bee n well describe d: 
"The physica l effect s .of methamphetami ne a r e quite va r iable 
de pending on dose , duration of dr ug use , mental state 
and dr ug environment of the indivi dual user . I n general, 
ho1vever , aft er the intravenous user i n jects the dr ug i n 
s uff i cient quant i t y , he experiences a 11 fl ash or ru s h" 
which he descr i bes as orgasmic i n nature . Af t e r t his 
init i a l experi ence , he us ually becomes euphoric , 1v i th 
an increase i n motor and s peech activi ty. The i ndividual 
may stay hyper active f or many hour s with no s i gns of 
f atigue . .. This act i on phase of s t i mul at ion may l ast 
f or s everal days i n whi ch the i ndividual does not s l ee p 
and r a r ely eat s . For a var iet y of r easons , thi s act ion 
phase t e rminat es , however . The use r may s top volunta r i l y 
because of fat i gue , he may bec ome c onf used, par anoi d, or 
panic- s t r i cken and s top "s hooting ", or he may simply r un 
out of drug. 11 (7) 
Approximate l y 24 hours aft er t he l ast dose of t he dr ug , · abs t i n-
ence mani fest s itsel f by acute me nta l de pressi on, fat i gue , 
de presse d r es pi r ation and a l ow body temperature· By 48 hour s , 
t he i ndi vi dual is almost completel y apat het i c whenever he is 
not busi l y s l ee pi ng . He must be wat che d as in a waki ng moment 
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he may att empt to commi t s uici de . His muscula r st~ en~J~, how-
ever, is almost nil. Afte r a 96 houP period, t he 1nd1v1dual. 
appea l'S r elat ivel y no t•mal , but 1vill not be normally res pons1 ve 
for a mont h aft er cessation of t he dPug . I f t he dr ug abuse has 
been mainta ine d ove r a long period of time , t he r e wi ll be a 
permanent dis integt•ation of personal i t y and a l ower1ng of I Q · 
Cont inue d chron ic use of the amphetannnes masks. fa t 1gue s t ates 
(pedodi c s l ee p and rest a r e essentia l for r epa1r and ma1ntenance 
of nerve tissue ) and t his event ual l y l ea ds to act ual degener-
ation of tissue , l owe d ng of IQ, etc. He nce t he te rm "S pee d 
Kill s ".( 6 ) 
The basic chemica l struct uPe is a phenyl ethylami ne nucleu~ 
(F ig. 1) . Any modification, a ddition or ~ubtraction to ~h1s . 
s t r ucture will ac ce nu c:te, reduce or abol 1sh s ome se l ect 1 ve act 1on( 8 ) · 
Amphetami nes stimulate activit y i n the me dial 
__ t he r eward system. ( 9 , 10) 
fo r ebra in bundles 
Stimulation of t his area i s 
experienced by an i ndividual 
as pleasure ( euph or ia ). The 
r et icula r activating system is 
als o aroused by amphet ami nes . 
Stimulat i on of t his area makes 
an i ndividua l more al ert and 
more awa r e of his environment. 
For a deta ile d explanation of 
t he mechani s m o f action of t he 
amphet ami nes see refe r ences 
number 8 , I 0 and 11 . 
The obvious effects of t he 
chronic use of amphetamines 
(loss of wei ght , fatigue and 
addi ct i on) are not the most 
detrimental. A more s ubtl e , 
but much mor e sever e c ompli -
cation, i s the deve lopment of 
a paranoid psychosis . ( 4, 8 , 10, 
12, 13) Heavy amphetami ne 
user s become s us picious and 
hostile , develop i ng fee lings 
that can l ea d t o vio l ence . ( 4, 
13) 
The amphet amine psychos i s has 
been 1vell r esearche d and i s 
des cr i be d as fo llows : 
(9-Phe nyl ethyl ami ne 
1-Phenyl-2- aminopr opane 
(~,.!-Amph et amine , Be nzedrine ) 
fi_CHz- ~- N~H 
~ dlf; 'Cfl; 
N, .(. - Di methylphenyl ethyl ami ne 
( ~let hamphet ami ne , Spee d) 
FIG. 1 St r uctures of @-Phe nyl -
ethyl amine and Amphetami nes 
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11 a well-defined syndrome of a paranoid state with auditory 
and visual halluci nations in a setting of clear conscious-
ness ... two distinctive features of amphetamine psychosis 
are the prominence of visual hallucinations in some cases 
and the absence of thought disor der i n al l cases. 11 
The incidence of hallucinations and psychosis with chronic use of 
the amphetamines is interesting when one cons iders the structural 
similarity, between the amphetamines and the mescaline-like agents 
(Fig.2). 
FIG. 2 3, 4, 5-Trimethoxyamphetamine { n1A) 
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ciate receiving letters of comment about the articles that 
published in the Bulletin. Please write with any comments that 
may have and if there is space we will be pleased to publish 
editors, would appreciate topics for future issues. At the 
time we are planning on issues of the Bulletin featuring, 
heroin and the opiates, marihuana, and would appreciate 
on the hallucinogenic amphetamine derivatives. 
detailed information on the amphetamines, we suggest 
you see reference 13. Very good, covers many aspects of 
use and abuse of these compounds. 
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